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Human Adipose-derived mesenchymal stem/stromal cells (hASCs) are of great interest
because of their potential for therapeutic approaches. The method described here
covers every single step necessary for hASCs isolation from subcutaneous abdominal
adipose tissue, multicolor phenotyping by flow cytometry, and quantitative determination
of adipogenic differentiation status by means of lipid droplets (LDs) accumulation, and
Western blot analysis. Moreover, to simultaneously analyze both LDs accumulation and
cellular proteins localization by fluorescence microscopy, we combined Oil Red O (ORO)
staining with immunofluorescence detection. For LDs quantification we wrote a program
for automatic ORO-stained digital image processing implemented in Octave, a freely
available software package. Our method is based on the use of the traditional low cost
neutral lipids dye ORO, which can be imaged both by bright-field and fluorescence
microscopy. The utilization of ORO instead of other more expensive lipid-specific
dyes, together with the fact that the whole method has been designed employing
cost-effective culture reagents (standard culture medium and serum), makes it affordable
for tight-budget research laboratories. These may be replaced, if necessary or desired,
by defined xeno-free reagents for clinical research and applications.
Keywords: mesenchymal stem/stromal cells, adipose tissue, characterization, adipogenic differentiation, lipid
droplets, fluorescence microscopy, staining, Oil Red O
INTRODUCTION
The concept of white adipose tissue (WAT) has changed dramatically over the last decades.
The identification of stable mesenchymal stem/stromal cells (MSCs) in WAT, called human
Adipose-derived MSCs (hASCs), transformed WAT from a passive energy depot to a promising
stem cells source. Compared to human Bone Marrow-derived MSCs (hBMSCs), hASCs are more
easily accessible, and their isolation yield higher amount of stem/stromal cells, without ethical
concerns (Zhu et al., 2008). These advantages, in addition to those shared with other stem/stromal
cells, make the hASCs of high interest for cell therapies and tissue engineering (Strem et al., 2005).
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For hASCs isolation, once the WAT is harvested through
a liposuction procedure (liquefied form) or abdominal
dermolipectomy (solid form), it is subjected to mechanical
disruption and washing. Then, the hASCs are detached from the
surrounding tissue by enzymatic digestion. Although a number
of articles described this process (Zuk et al., 2001; Gimble and
Guilak, 2003; Lee et al., 2004; Dicker et al., 2005; Locke et al.,
2009; Bourin et al., 2013; Ge et al., 2016; Kim et al., 2016), most
lack detailed technical information, depicting images, molecular
characterization or quantification of adipogenic differentiation.
In addition, to resolve a protein extract from adipogenic-linage
differentiated hASCs by SDS-PAGE, higher concentration of
detergent in the lysis buffer is required, an ignored fact in
most articles. Here, we present a comprehensive protocol for
hASCs isolation, culture, molecular characterization, adipogenic
differentiation, LDs and cellular proteins double-staining [with
Oil Red O (ORO) and direct or indirect immunofluorescence
(IF), respectively], image-based LDs quantification, and protein
analysis by Western blot (WB). The key features of our protocol
are:
- Compared to previously reported, this protocol represents
the most comprehensive contribution, covering every step
from isolation of hASCs to quantitative determination of their
adipogenic potential.
- We employed low-cost culture reagents, constituting a
cost-effective tool for tight-budget laboratories. These may
be replaced by defined xeno-free reagents for clinical
applications.
- We utilized the traditional low-cost neutral lipids dye
ORO, suitable for imaging both by bright-field and
fluorescence microscopy. Our classical isopropanol-
dissolved ORO-staining protocol was optimized to avoid
dye precipitation.
- We combined ORO-staining with IF technique to
simultaneously analyze LDs accumulation and localization of
cellular proteins. To our best knowledge, this combination has
not been previously described on cultivated cells.
- We wrote a program to automatically quantify cellular LDs
in both bright-field and fluorescence images. This program is
supplied as supplementary information.
LDs are present in a wide range of cell types both in health and
disease (Thiam et al., 2013). Their biogenesis and maturation
are related to lipid metabolism, which is unbalanced in insulin
resistance, obesity, and other lipid-related human disorders.
LDs carrying triacylglycerol (TAG) and cholesteryl esters are
emerging as dynamic cellular organelles generated in nearly every
cell, bearing key roles in lipid and membrane homoeostasis.
Abnormal LDs dynamics are associated with the pathophysiology
of many metabolic disorders as obesity, diabetes, atherosclerosis,
fatty liver, and even cancer (Hesse et al., 2013). Moreover,
multiple intracellular pathogens, including viruses, bacteria,
and parasites, specifically target host LDs during their life
cycle (Roingeard and Melo, 2017). Our manuscript could help
researchers interested in basic science of MSC, LDs, as well as
those interested in clinical studies. Besides hASC isolation it
includes:
- Characterization by multicolor flow cytometry by using the
Human MSC Analysis Kit from BD, based on the phenotypic
signature described by the International Society for Cellular
Therapy (ISCT) (Bourin et al., 2013) for reproducibly
phenotyping expanded MSCs.
- Differentiation of hASCs into the adipogenic lineage.
To induce differentiation, the adipogenic drug cocktail
composition and the induction time line have been optimized.
- ORO-IF double staining to analyze proteins of interest
in ORO-stained samples. These two procedures have been
applied previously on skeletal muscle (Koopman et al., 2001),
but not in cultured cells, in which other, more expensive,
lipid-specific dyes have been combined with IF (Melo et al.,
2011).
- LDs quantification. An automatic procedure for ORO-stained
cell digital image processing was created.
Undoubtedly, this report will be of great value for stem/stromal
cell and adipogenesis research, as well as for the analysis of
LDs in a wide range of cell types and conditions, especially in





- Actin: Rabbit anti-actin-FITC (Sigma-Aldrich, St. Louis, MO,
United States, catalog no.: F3777) and Mouse anti-actin (BD
Biosciences - Becton, Dickinson and Company, Franklin
Lakes, NJ, United States, catalog no.: 612656).
- Adipose Differentiation-Related Protein: Rabbit anti-ADRP
(Abcam, Cambridge, United Kingdom, catalog no.: ab52355)
- Early Endosome Antigen 1: Mouse anti-EEA1 (BD
Biosciences, catalog no.: 610456)
- 130 kDa cis-Golgi Matrix protein: Mouse anti-GM130 (BD
Biosciences, catalog no.: 610822)
- Bovine anti-mouse IgG (Santa Cruz Biotechnology, Santa
Cruz, CA, United States, catalog no.: sc-2371)
- Donkey anti-mouse IgG and donkey anti-rabbit IgG
Alexa Fluor 488 (Thermo Fisher Scientific, Waltham, MA,
United States, catalog no.: 21202 and 21206)
Other Reagents
- 0.2µmPVDF blottingmembrane (GEHealthcare Life science,
Buckinghamshire, United Kingdom, catalog no.: 10600021)
- 0.22 and 0.45µm nitrocellulose membrane (GE Healthcare
Life science, catalog no.: RPN2020D)
- 2-mercaptoethanol (Sigma-Aldrich, catalog no.: M-6250)
- 3-isobutyl-1 methylxanthine IBMX (Sigma-Aldrich, catalog
no.: I5879)
- Accutase R© (BD Biosciences, catalog no.: 561527)
- Acrylamide (Sigma-Aldrich, catalog no.: A-3887)
- Ammonium Persulfate, APS (Bio-Rad, Hercules, CA,
United States, catalog no.: 161-0700)
- BD StemflowTM hMSC Analysis Kit (BD Biosciences, catalog
no.: 562245)
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- Bovine serum albumin, BSA (Roche, Basilea, Switzerland,
catalog no.: 10735078001)
- Bromophenol Blue (Biopack, Zárate, Buenos Aires, Argentina,
catalog no.: 2000962201)
- Calcium chloride, CaCl2 (Sigma-Aldrich, catalog no.: 499609)
- Calf Serum (Natocor, Villa Carlos Paz, Córdoba, Argentina)
- Collagenase D (Roche, catalog no.: 11088882001)
- Coomassie Brillant Blue G250 (Bio-Rad, catalog no.: 1610406)
- Dexamethasone (Sigma-Aldrich, catalog no.: 46165)
- Dimethyl sulfoxide, DMSO (Biopack, catalog no.:
2000992007)
- Dulbecco’s Modified Eagle’s Medium DMEM (Thermo Fisher
Scientific, catalog no.:12800058)
- Ethanol (Anedra, Tigre, Buenos Aires, Argentina, catalog no.:
AN00927025)
- Ethylenediaminetetraacetic acid, EDTA (Biopack, catalog no.:
2000964506)
- Fetal Bovine Serum, FBS, Biotechnology Grade, heat
inactivated (Internegocios, Mercedes, Buenos Aires,
Argentina)
- Glacial acetic acid (Biopack, catalog no.: 2000165308)
- Glycerin (Biopack, catalog no.: 2000162008)
- Glycine (Sigma-Aldrich, catalog no.: G-8898)
- Hoechst (Sigma-Aldrich, catalog no.: H3570)
- Hydrochloric acid, HCl (Dalton, Mendoza, Argentina, catalog
no.: 0004801000)
- Insulin Humulin R, recombinant, human, 100 UI/mL,
sterile suspension (Eli Lilly and Company, Indianapolis, IN,
United States, catalog no.: HI-210)
- Isopropyl alcohol (Anedra, catalog no.: AN00620291)
- Magnesium chloride hexahydrate, MgCl2.6H2O (Biopack,
catalog no.: 2000962005)
- Methanol (Anedra, catalog no.: AN00619725)
- Mowiol 4-88 (Sigma-Aldrich, catalog no.: 81381)
- N, N, N′, N′-tetramethylethylenediamine, TEMED (Thermo
Fisher Scientific, catalog no.: 15524010)
- N, N′-Methylenebisacrylamide (Sigma-Aldrich, catalog no.:
146072)
- Non-faty dry milk
- Oil Red O (Biopack, catalog no.: 2000967402)
- Paraformaldehyde, PFA (Sigma-Aldrich, catalog no.: 441244)
- Phenylmethylsulfonyl fluoride, PMSF (Sigma-Aldrich, catalog
no.: P7626)
- PierceTM BCA Protein Assay Kit (Thermo Fisher Scientific,
catalog no.: 23227)
- Ponceau S (Biopack, catalog no.: 2000963003)
- Potasium chloride, KCl (Biopack, catalog no.: 2000163107)
- Potasium monobasic phosphate, KH2PO4 (Biopack, catalog
no.: 2000963506)
- Rosiglitazone (Laboratories Beta, Buenos Aires, Argentina, cat.
no.: 476863-2)
- Saponin (Biopack, catalog no.: 2000946003)
- Sodium bicarbonate NaHCO3 (Sigma-Aldrich, catalog no.:
S-6015)
- Sodium chloride, NaCl (Biopack, catalog no.: 2000164608)
- Sodium dibasic phosphate, Na2HPO4 (Merck Millipore,
Billerica, MA, United States, catalog no.: 106559)
- Sodium dodecyl sulfate, SDS (Genbiotech, Sophia Antipolis,
Maritime Alps, France, catalog no.: RU2408)
- Sodium hydroxide, NaOH (Sigma-Aldrich, catalog no.:
221465)
- Sodium monobasic phosphate monohydrate, NaH2PO4.H2O
(Sigma-Aldrich, St. Louis, MO, United States, catalog no.:
S-3522)
- Sulfosalicylic acid (Sigma-Aldrich, catalog no.: S-3147)
- Super Signal R© West Pico Chemiluminescent Substrate
(Thermo Fisher Scientific, catalog no.: 34077)
- Triclhoracetic acid (Merck Millipore, catalog no.: 100807)
- Trizma base (Sigma-Aldrich, catalog no.: T1503)
- Trypsin 1:250 (Thermo Fisher Scientific, catalog no.:
27250018)
- Tween-20 (Sigma-Aldrich, catalog no.: P9416)
Other Materials
- 0.60µm nylon mesh (Merck Millipore, catalog no.:
NY6000010)
- 1.5mL polypropylene conical microcentrifuge tubes (Extra
Gene, Taichung, Taiwan, China, catalog no.: TUBE-170-C)
- 10 cm diameter tissue culture plate (Jet Biofil R©, Guangzhou,
Cantón, China, catalog no.: TCD010100)
- 15mL polypropylene conical centrifuge tubes (Biologix, Jinan,
Shandong, China, catalog no.: 10-0152)
- 50mL polypropylene conical centrifuge tubes (Extra Gene,
Taichung, Taiwan, China, catalog no.: P1013-50BF)
- Cover slips round 12mm (Thermo Fisher Scientific, catalog
no.: 50-143-822)
- Cryovials (Extra Gene, catalog no.: CR-2.0EB-S)
- Filter, autoclavable 3mm wire mesh round filter, 3.5mm
diameter
- Flask, autoclavable glass flask with the same diameter as the
3mm wire mesh round filter.
- Neubauer chamber (Marienfeld, Lauda-Königshofen,
Alemania, catalog no: 0610039094)
- Petri dish (Nest, Rahway, NJ, United States, catalog no.:
752001)
- Plastic bag, sliding closure polipropilene bag, 20× 20 cm
- Scissors, autoclavable operating scissors, Vantage-Miltex. Inc.,
Plainsboro, NJ, United States, catalog no.: V95-22)
- Serological pipettes, sterile, disposable (Jet Biofil R©, catalog no.:
GSP012010)
- Surgical blades, gamma radiation sterilized (Holden medical
B.V., Lelystad, The Netherlands, no. 3.13)
- Surgical forceps, autoclavable (Roboz Surgical Instrument Co.,
Inc., Gaithersburg, MD, United States, catalog no.: RS-8100)
- Whatman cellulose filter paper, Ashless Quantitative Filter
Paper, 20–25µm, 9 cm; (Whatman plc-GE Healthcare catalog
no.: 1441-090 41)
- No datasets were generated for this study.
Recipes
ATTENTION All solutions described are prepared with Milli-Q
quality water (or similar).
10 X PBS (Stock solution, 200mL)
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Dissolve 16 g of NaCl, 0.4 g of KCl, 2.84 g of Na2HPO4, and
0.54 g of KH2PO4 in 200mL of water. Sterilize by autoclave. To
prepare 1 X PBS solution dilute 1:10 with sterile water before use.
REST This solutionmay be kept at RT, 4◦C, or−20◦C for long
term storage.
1 X PBSCM (50mL)
Add 50 µL of 1MMgCl2 and 50 µL of 1M CaCl2 in 50mL of
1 X PBS.
REST This solutionmay be kept at RT, 4◦C, or−20◦C for long
term storage.
2% Collagenase (Stock solution, 15mL)
Dissolve 0.3 g of collagenase in 15mL of 1 X PBS and sterilize
by filtration through a 0.22µm nitrocellulose membrane.
REST Single use aliquots of this solutions are kept at −20◦C
for long term storage.
2.5% Trypsin (Stock solution, 100mL)
Dissolve 2.5 g of Trypsin and 0.85 g of NaCl in 100mL of
water, and sterilize by filtration through a 0.22µm nitrocellulose
membrane.
REST 12mL aliquots of this solution are stored at
−20◦C. These aliquots may be thawed and frozen several
times.
0.5% Trypsin/EDTA (Stock solution, 10mL)
Dissolve 0.5 g de Trypsin, 0.15 g of EDTA, and 0.085 g of NaCl
in 10mL of water, and sterilize by filtration through a 0.22µm
nitrocellulose membrane.
REST 1mL aliquots of this solution are kept at−20◦C for long
term storage.
Adipogenic differentiation Induction Cocktail (10mL)
Component Volume (µL) Final concentration
2.5mM Dexamethasone 1 250 nM
20mM Rosiglitazone 1 2µM
50mM IBMX 100 0.5mM
4.17 mg/mL Insulin (ready to use
sterile suspension, commercial)
24 10µg/mL
TIP Prepare this solution just before each use.
ATTENTION The volumes indicated in the table above
correspond to the one used for a single 10 cm diameter culture
dish. It is necessary to scale up or down to the volume necessary,
according to the culture well, dish or flask (and the number of
them) to be used.
2.5mM Dexamethasone (Stock solution, 1.25mL)
Dissolve 12mg of Dexamethasone in 1.25mL of absolute
ethanol, and sterilize by filtration through a 0.22µm
nitrocellulose membrane.
REST 40 µL aliquots of this solution are stored at −20◦C for
up to 2 years.
20mM Rosiglitazone (Stock solution, 840 µL)
Dissolve 8mg of Rosiglitazone in 840µL of DMSO, centrifuge
10min at 25◦C, and sterilize by filtration through a 0.22µm
nitrocellulose membrane.
REST 40 µL aliquots of this solution are stored at −80◦C for
up to 2 months.
50mM 3-isobutyl-1 methylxanthine (IBMX, Stock solution,
500 µL)
Dissolve 5.75mg of 3-isobutyl-1 methylxanthine in 450 µL of
water with 50 µL of NaOH, and sterilize by filtration through a
0.22µm nitrocellulose membrane.
REST 40 µL aliquots of this solution are stored at −20◦C for
up to 3 months. These aliquots may be thawed and frozen several
times.
4% PFA solution, pH 7.2–7.4 (50mL)
Dissolve 2 g of PFA in 10mL of water at 80◦C, add
approximately 5mL of 16N NaOH (drop by drop) while stirring
until the PAF is dissolved. Then add 20mL of 1% NaH2PO4
solution and 20mL of 1.6%Na2HPO4 solution. Once the solution
is cold adjust the pH with 3N HCl.
REST 4mL single use aliquots of this solution are kept at
−20◦C for long term storage.
ATTENTION Once thawed, these aliquots should not be
frozen again, because of the risk of crystallization.
0.35% Oil Red O (Stock solution, 10mL)
Dissolve 0.35 g of Oil Red O in 10mL of isopropyl alcohol.
Filter twice, first through a 0.45µm, and then through a 0.22µm
nitrocellulose membrane. To prepare the working solution, which
should always be done just before use, dissolve 6 parts of ORO
stock solution in 4 parts of water, and filter through a 0.22µm
nitrocellulose membrane.
REST ORO stock solution can be stored for up to 2 months at
RT and protected from light.
ATTENTION Always pay special attention to the presence of
precipitates before using this solution. Discard if precipitates are
found.
2.5% Saponin/10% BSA (Stock solution, 10mL)
Dissolve 0.25 g of saponin and 1 g of BSA in 10mL of water.
REST 1mL aliquots of Saponin/BSA solution are kept at
−20◦C for long term storage.
13.3% Mowiol (18mL)
Dissolve 2.4 g of Mowiol 4–88 in 6 g of Glycerol. Add 6mL
of water and leave for 2 h at RT. Add 12mL of 0.2M Tris-HCl
(pH 8.5) and incubate at 50◦C for 10min with occasional mixing.
After the Mowiol dissolves, clarify by centrifugation at 5,000 × g
for 15min.
REST 1mL aliquots of this solution are kept at−20◦C for long
term storage. These aliquots are stable at room temperature or
4◦C for several months after thawing.
Cell Lysis Buffer (20mL)
Dissolve 0.14 g of Tris (Trizma base) and 0.4 g of SDS in 15mL
of water. Once dissolved, adjust the pH to 6.8 pH with 3N HCl.
Add distilled water up to 20mL. Just before use add 10M PMSF.
REST This solution is stable at RT for several
months.
5 X Protein sample buffer (Stock solution, 10mL)
Dissolve 10mg of bromophenol blue, 1 g of SDS, 5mL of
Glycerol, 2.5mL of 1M Tris-HCl (pH 6.8), and 0.5mL 2-
mercaptoethanol (see below) in water.
REST 1mL aliquots of this solution are kept at−20◦C for long
term storage without the addition of 2-mercaptoethanol. After
thawing, add the corresponding volume of this reagent. These
aliquots are stable at RT or 4◦C for several months after thawing.
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0.25% Coomassie Brillant Blue (300mL)
Dissolve 0.75 g of Coomassie Brillant Blue G-250 in 270mL of
ethanol:water (1:1 v/v) and 30mL of glacial acetic acid. Filter the
solution through a Whatman filter paper to remove particulate
matter.
REST This solution is stable at RT for several months. It may
be reused many times.
2% Ponceau S (100mL)
Dissolve 2 g of Ponceau S, 30 g of triclhoracetic acid, and 30 g
of sulfosalicylic acid in 100mL of water.
REST This solution is stable at RT for several months. It may
be reused many times.
12% Acrylamide Resolving gel (7.5mL)
Component Volume (mL) Final
concentration
Glycerol 1 13.40%




20% SDS 0.037 0.10%
TEMED 0.003 0.04%
10% APS 0.037 0.05%
H2O 1.45 –
7.4% Acrylamide Stacking gel (2.5mL)
Component Volume (mL) Final
concentration




20% SDS 0.0125 0.10%
TEMED 0.0025 0.10%
10% APS 0.025 0.10%
H2O 1.5 –
10 X Laemmli Running Buffer (Tris-glycine, Stock solution,
500mL)
Dissolve 15.2 g of Tris (Trizma base), 72.1 g of Glycine, and 5 g
of SDS in 500mL of water. To prepare 300mL of the 1 X running
buffer dilute 1:10 with water.
REST This solution is stable at RT for several weeks.
ATTENTION Do not adjust the pH, as the addition of
electrolytes would cause the current to increase too much.
Discard if this solution turns yellowish, which is due to Glycine
oxidation.
1 X Towbin Protein Transfer Buffer, pH 8.3 (1 L)
Dissolve 3.03 g of Tris (Trizma base), 14.4 g of Glycine, and 1 g
of SDS in 800mL of water. Add methanol up to 1 L.
REST This solution is stable at RT for several weeks.
ATTENTION Do not adjust the pH as the addition of
electrolytes would cause the current to increase too much.
0.1% PBST (Stock solution, 200mL)
Add 200 µL Tween-20 to 200mL of 1 X PBS. To prepare
200mL of the 0.01% PBST solution dilute 1:10 with 1 X PBS
before use.
REST This solution is stable at RT for several months.
5%Western blot blocking solution (10mL)
Dissolve 0.5 g of non-fat drymilk in 10mL of 1 X PBS or 0.01%
PBST.
REST This solution is ideally prepared just before, and may be
stored at 4◦C for a few days. Addition of preservatives (as 0.02%
Sodium azide) may prolong its shelf life.
Equipment
- ZEISS Primo Vert Inverted Microscope (Zeiss; Oberkochen,
Baden-Württemberg, Germany)
- Class II Biological Safety Cabinet (Biobase; Zhangqiu,
Shandong, China)
- Sanyo MCO-19AIC CO2 cell incubator (Sanyo; Moriguchi,
Osaka, Japan)
- Innova 4000 Incubator Shaker (New Brunswick Scientific,
Enfield, CT, USA)
- Jouan B4i Multifunction Centrifuge (Thermo Fisher Scientific,
Waltham, MA, USA)
- AccuriTM C6 Cytometer (BD Biosciences)
- Eclipse TE2000 Inverted Microscope (Nikon, Shinagawa,
Tokyo, JPN)
- ImageQuantTM LAS 4000 (GE Healthcare Life Sciences,
Chicago, IL, USA)
- Reusable bottle-top filters (Note: Convenient, disposable
bottle-top filters are available from a number of manufacturers.
Reusable bottle-top filters provide a more cost-effective
solution for laboratories on a more restricted budget).
STEPWISE PROCEDURES
Isolation of Human Adipose-Derived
Mesenchymal Stem/Stromal Cells (hASCs)
ATTENTION As a source of hASCs, we routinely use
subcutaneous white adipose tissue (either solid or lipoaspirates)
obtained from healthy donors undergoing esthetic surgical
procedures. A picture of the way we receive solid tissue
samples can be found in Figure 1A. This protocol was
developed in accordance with the recommendations of
the Universidad Nacional de Cuyo Bioethics guidelines,
Universidad Nacional de Cuyo Bioethics Committee. The
protocol was approved by the Universidad Nacional de
Cuyo Bioethics Committee. All subjects gave written
informed consent in accordance with the Declaration of
Helsinki.
REST The donated tissue may be stored at 4◦C until
processing. We routinely do it the day after, but have had good
results from solid tissue stored for up to 3 days. In lipoaspirates
the hASCs are not preserved so well, thus, processing should be
done as soon as possible.
Initial Notes
- All human-originated biological material must be considered
as pathological, and as such, extreme care and adequate
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FIGURE 1 | Isolation of mesenchymal stem/stromal cells from human solid adipose tissue. (A) solid white adipose tissue samples are received in 120mL disposable
sterile plastic containers, (B) the samples are placed on a Petri dish before starting their dissection, (C) fat is separated from skin (which is discarded), (D) fat tissue is
cut with scissors, (E) fat is cut further with surgical blades, (F) fat is rinsed with PBS buffer in polypropylene conical tubes, (G) obtaining of three phases after filtration
and centrifugation, (H) separation of the stromal vascular fraction (SVF) from the other two phases, (I) seeding the washed SVF in 10 cm diameter plate with
supplemented DMEM.
personal protective equipment should be used during
manipulation. An appropriated protocol for the disposal
of human material should be followed according to your
Institution’s pathological wastes.
- All solutions and equipment coming into contact with cells
must be sterile, and an aseptic technique should be used
accordingly, in a Class II biological safety cabinet.
- All centrifugation steps are performed at room temperature
(RT) unless other temperature is specified.
- We routinely employ 10 cm diameter culture plates, although
75 cm2 cell culture flasks may be used as well.
- All cellular cultures are performed in a humidified 37◦C,
5% CO2 incubator. We routinely utilize high glucose
supplemented Dulbecco’s Modified Eagle Medium (DMEM),
which is composed by: high glucose DMEM, 10% Fetal Bovine
Serum (FBS, 1 h inactivated at 60◦C), 100 U/mL Penicillin-
100µg/mL Streptomycin.
1. If the starting material is solid adipose tissue, place it on a
sterile Petri dish employing sterile forceps, see Figure 1B.
Leave the dish lid aside to support the surgical instruments.
Remove the skin, Figure 1C, and cut small pieces of
adipose tissue (yellow colored, Figures 1D,E from the same
panel) while removing blood vessels and connective tissue
(whitish-pink colored) with sterile scissors. This step takes
∼30 min/100 g of fat tissue.
2. Wash four times with Phosphate Buffer Saline (PBS:
0.13mM NaCl, 2.70mM KCl, 10mM Na2HPO4, 2mM
KH2PO4, pH 7.4) placing the fat tissue pieces in a 50mL
polypropylene conical tube, close hermetically and shake.
Discard the PBS using a 10mL serological pipette. Repeat
the wash three more times. When the PBS looks clean,
without blood, Figure 1F, place the washed fat again on
the Petri dish to continue the dissection. We usually obtain
clean material after four washes, but more washes could be
performed if needed. After the washing step, small blood
vessels become more visible, which facilitates their removal
with scissors. Chop further the adipose tissue pieces with
the aid of a surgical scalpel and clamps until obtaining a
soft consistency. This step takes ∼30min. and yield 60mL
of processed fat/100 g of fat tissue.
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3. If the starting material is lipoaspirate (fat from a liposuction
procedure), the protocol starts at this current step, or continue
the protocol started within the previous steps from solid tissue.
Wash with PBS as explained in step 2. For each wash add
PBS, shake and centrifuge the tube at 200 × g in a swinging
bucket rotor for 3min. Remove the PBS with a 10mL
serological pipette.
TIP As the PBS will be below the adipose tissue, and to
avoid blocking the pipette, expel air as you go down vertically
through the adipose phase with the pipette. Wash until the
PBS looks clean (without blood), usually twice if the starting
material was solid fat, or up to 5 washes if you started from
lipoaspirate. These washes take ∼45min for 60mL of fat
divided in two conical tubes.
4. Transfer the fat to a fresh 50mL conical tube without
exceeding 30mL of fat/tube. If you have more than 30mL
of fat, divide it into two tubes. Add trypsin and collagenase
to final concentrations of 0.25 and 0.1%, respectively, to
digest the remnant tissue pieces. Incubate 30–40min at 37◦C
with gentle shaking in horizontal position. Alternatively,
decreasing collagenase concentration to 0.05% with 1 h
incubation time gives also enough tissue digestion.
TIP It may be required to adjust optimal enzyme
concentrations. Collagenase lots may vary in activity, and
too much activity may kill the cells. However, too low
activity would not digest enough the tissue for an adequate
stem/stromal cells release. The incubation time may also
depend on the enzyme lots and should be adjusted as
necessary.
ATTENTION Place the tubes tightly closed inside a
hermetically closed plastic bag, and put the bag inside a
plastic container for biological safety.
5. Add enough supplemented DMEM to double the initial
fat volume, or if such volume is more than 25mL, add
supplemented DMEM up to 50mL. This step inactivates the
digestive enzymes.
6. Filter through a 3mm wire mesh while mixing (above the
filter) with a tip to prevent the connective tissue to clog
the filter. Collect the liquid phase (supplemented DMEM
+ dissociated cells) in a wide opening flask with the same
diameter as the filter, which has been firmly secured to the
flask opening with paper tape and autoclaved. This step takes
∼20min for 60mL of digested tissue.
7. Transfer the liquid filtrate to a 50mL conical tube and
centrifuge in a swinging bucket rotor for 10min at 400 ×
g to obtain three phases that may be clearly visualized in
Figure 1G: (i) the upper yellowish liquid layer composed of
oil released from broken adipocytes; (ii) the middle white
compact layer which contains unbroken adipocytes and pre-
adipocytes; and (iii) a reddish aqueous phase (the color is
due to the phenol red indicator included in DMEMmedium)
with a cellular pellet called stromal vascular fraction (SVF),
which includes an heterogeneous population with mature
blood, stem, stromal, and progenitor cells. Transfer the lower
phase, including the SVF to a new Falcon tube, Figure 1H.
8. Centrifuge in a swinging bucket rotor for 10min at 400 × g
to re-obtain the SVF.
9. To wash the SVF, first, discard the supernatant, then, re-
suspend the pellet (SVF) in 15mL of DMEM and finally
centrifuge again, as described in step 8.
TIP This pellet is extremely labile; thus care should
be taken when aspirating the media from above to avoid
aspirating it.
10. Suspend the SVF in 10mL of supplemented DMEM and
transfer it to a 10 cm diameter tissue culture plate, Figure 1I.
Culture the cells in a humidified 37◦C, 5% CO2 incubator.
Steps from 7 to 10 take∼45min.
11. After 24 h, take the plate out of the incubator taking care of
moving it as little as possible. It is expected to find turbidity
in the culture medium due to the presence of a large amount
of floating and/or decanted red blood cells. Employing a
phase-contrast inverted microscope, look for adherent cells
with fibroblastoid morphology attached to the bottom of
the plate. These often appear surrounded by a small circle
deprived of red blood cells (too much movement of the
plate would disassemble this pattern, which is useful for
rapidly detecting the adherent cells). Gently, wash 3 times
with PBS and add fresh supplemented DMEM. These washes
remove specifically red blood cells keeping the adherent
cells, which correspond mainly to mesenchymal stem and/or
stromal cells, in this case, hASCs. This firstly obtained hASCs
population is considered passage “0.”
TIP Although the cells are firmly attached to the plastic
surface, it is always recommended to work gently, especially
when adding media or PBS to the cell culture. These should
be warmed at 37◦C before being added to the cells. The
addition should be done carefully, through the culture plate
walls, and not directly over the cells, as hASCs are susceptible
to stressful manipulation.
12. Wash and add fresh supplemented DMEM every day until
red blood cells are not further detected.
13. Continue feeding the hASCs with fresh supplemented
DMEM every 2 or 3 days until the monolayer reaches∼90%
confluency.
TIP Never allow the hASCs to reach 100% confluency as
this may cause spontaneous differentiation and lose of the
multipotency potential.
hASCs Expansion
14. Discard the medium and wash the cell monolayer twice, each
time with∼5mL 37◦C pre-warmed sterile PBS.
15. Detach the hASCs with warm 0.05% trypsin/EDTA solution
(500µL is enough for a 10 cm diameter plate). It is important
to minimize the exposure to trypsin/EDTA as the cells will
die. Place the plate with trypsin into the cell incubator for
30 s, the cells will “round up” when detached.
TIP Closely monitor the cells under the inverted
microscope to identify when most of the cells are detached.
It may be necessary to help mechanically, through gently
tapping the plate by its side. All this procedure should take
<2min.
16. Add 6 volumes (3mL) of supplemented DMEM to the
trypsin reaction, and collect the cells employing a sterile
serological pipette. Transfer the cells to a 15mL conical tube.
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17. Pellet the cells by centrifugation in a swinging bucket rotor
at 400× g during 5min.
18. Discard the supernatant (trypsin-containing medium) and
replace it with 1mL of fresh supplemented DMEM.
19. Employ an aliquot (10 µL) to count the cells in a Neubauer
chamber. Apply the following formula: cells/mL = (number
of cells counted/number of quadrants) ∗ 104. Dilute as
needed to seed flasks, plates, or wells with 0.7–1 × 104
cells/cm2.
hASCs Characterization by Flow Citometry
20. To characterize hASCs, we routinely employ the “BD
StemflowTM hMSC Analysis Kit” for reproducible multicolor
phenotyping of mesenchymal stem cell expansions (BD
Biosciences). This kit includes a mixture of three antibodies
(conjugated with different fluorophores) that recognize
hMSCs positive surface markers: CD90-FITC, CD105-
PerCP-CyTM 5.5 and CD73-APC (positive cocktail), and
a mixture of 5 single fluorophore (PE)-labeled antibodies
that recognize surface markers of other cell types different
from hMSCs: CD45, CD34, CD11b, CD19, and HLA-DR
(negative cocktail). For compensation, CD90-FITC, CD44-
PE, CD105-PerCP-CyTM 5.5, and CD73-APC are used. The
kit also includes the corresponding isotype controls.
21. Grow the hASCs to 90% confluency in a 10 cm diameter
culture plate under standard conditions (supplemented
DMEM, 37◦C and 5% CO2).
22. Wash with PBS buffer and detach the cells by addition of
500 µL of Accutase R© (BD Biosciences). This is a natural
enzyme mixture with proteolytic and collagenolytic enzyme
activity, which preserves most epitopes for subsequent flow
cytometry analysis. Incubate for 10 s at 37◦C.
23. Inhibit the enzymatic reaction by adding 3mL of
supplemented DMEM, which neutralizes the enzymes
activity. Collect the cells by gentle pipetting.
24. Transfer the cells into a 15mL conical tube and centrifuge at
200× g for 5min at RT.
25. Discard the supernatant and re-suspend the cell pellet with
600µL of a solutionmade of 1% v/v calf serum in PBS (Wash
and Label Solution, WLS). Filter through a 0.60µm nylon
mesh.
26. Count the cells in a Neubauer chamber, and place 50,000
cells in each cytometer tube together with the corresponding
antibodies (0.5–2 µL/tube with cells), following the
instructions from the manufacturer.
27. Incubate the tubes on ice, in the dark, for 30min.
28. Washing step: add 200 µL of WLS and centrifuge at 200× g
for 5min. Repeat this step a second time and after the second
wash, remove the supernatant.
29. Re-suspend the pellet in 150 µL of PBS.
30. Analyze and quantify the samples by using the FlowJo
software version 7.6 in an AccuriTM C6 cytometer (BD
Biosciences, USA) or equivalent, Figure 2.
Cryopreservation
31. Following expansion, it is recommended to cryopreserve
hASCs at passage 2.
32. When the cell density reaches ∼0.8–1 × 104 cells/cm2
(which corresponds to a coverage of 80–95% of the plate
surface with attached cells), proceed as described in steps
14–17 to wash and detach the cells.
33. After centrifugation, discard the trypsin-containing medium
and replace it with freezing medium (10% FBS, 10% DMSO,
DMEM) at a volume of 1 mL/10 cm diameter culture plate
employed for producing the pellet. This will result in a
freezing density of∼5–8× 105 cells/mL.
34. Employ a 5mL serological pipette to suspend the cells, then
place 1mL aliquots of cells into cryovials and place them
immediately into a controlled freezing system as the one
explained in the next step.
35. hASCs require a controlled freezing rate of −1◦C/min.,
otherwise the mortality reaches almost 100%. Many systems
are currently available to control the freezing rate. We
use an alcohol-based cell freezing container, which requires
fresh supply of 100% isopropyl alcohol, to maintain an
approximate −1◦C/min freezing rate. Place the cryovials
into the container with isopropyl alcohol at RT, and the
container in an−80◦C freezer for at least 16 h.
36. The next day (or within the week), transfer all cryovials into
a liquid nitrogen tank, for long-term storage.
37. To culture the frozen cells, transfer the cryovials from the
liquid nitrogen tank to a 37◦C water bath. Thaw until a small
piece of ice is visible inside the cryovial, and pour it in 5
or 6 volumes of 37◦C pre-warmed supplemented DMEM
contained in a plastic conical tube. Gently move the closed
tube to wash out the DMSO from the cells.
38. Pellet the cells by centrifugation in a swinging bucket rotor
at 400× g during 5min.
39. Discard the supernatant (DMSO-containing medium) and
replace it with 10mL of 37◦C pre-warmed supplemented
DMEM.
40. Pipette gently and transfer to a 10 cm diameter-culture plate
or T-75 flask.
TIP Cells will grow to 100% confluency in about 3–7
days after trypsinization or cryopreservation if the starting
confluency is above 30%. Seeding densities lower than
30% usually result in the change of the typical fibroblast
morphology to widen, expanded, and highly branched, and
in a decrease of proliferation capacity. Proliferation of hASCs
also dramatically decreases by passage 10, when the shape
gradually changes again from fibroblastic to expanded and
branched. Experiments should be done ideally with hASCs
at passages 3–6.
hASCs Adipogenic Differentiation
41. Place a sterile round cover slip (10–12mm diameter) in each
well of a 24-well plate to be used.
42. Seed 45,000 hASCs/well. After 24–36 h, the cells should reach
80–90% confluency.
43. Replace the culture medium by the induction one, consisting
of supplemented DMEM with 250 nM dexamethasone,
0.5mM 3-isobutyl-1 methylxanthine (IBMX), 2µM
rosiglitazone and 10µg/mL insulin. This will be considered
day 0 (Figure 3).
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FIGURE 2 | Multicolor phenotyping of hASCs by flow citometry. Histograms represent the number of events (count) vs. the relative fluorescence units (FRU) for each
indicated fluorophore conjugated-antibody or cocktail. (A) Representative graphs of a population with most of the cells positive for CD90, CD105, and CD73.
(B) Representative graphs of a different population of cells which did not express CD105.
FIGURE 3 | Adipogenic differentiation induction time line. ADM, Adipogenic Differentiation Medium; ORO, Oil Red O.
TIP Stock solutions are prepared, stored and used as
detailed below, under the RECIPES section.
44. Incubate the cells with induction medium during 3 days,
followed by 2 days in supplemented DMEM with 10µg/mL
insulin. Untreated (control) cells are grown in 5% v/v FBS
supplemented DMEM, which is changed using the same
schedule applied to the treated cells until the end of the
experiment (Figure 3).
45. A second induction step with the adipogenic cocktail is
left for 2 additional days, followed by 1 day incubation in
supplemented DMEM with 10µg/mL insulin (Figure 3).
46. Finally, a third and last induction is left for 2 additional days
(Figure 3).
47. Lipid droplets (LDs), which look like bright refractive round
structures on a phase-contrast inverted microscope, become
visible at day 5 after induction. The LDs grow in size and
number as the adipogenic differentiation progresses.
3.6. Fixation and Oil Red O staining
48. Prepare 0.35% w/v ORO (Biopack, Argentina) stock solution
in isopropanol and incubate overnight at RT as detailed
in the RECIPES section. Filter the stock solution twice,
first through a 0.45µm and then through a 0.22µm
nitrocellulose membrane.
ATTENTION This step is CRITICAL, as the presence
of precipitates would prevent visualization and accurate
quantification of ORO-stained LDs. Before using this
solution it is again CRITICAL to pay attention to the
formation of precipitates. If this occurs discard this stock
solution to avoid plugging the nitrocellulose filter and start
this step (number 45) again.
49. Wash the cells three times with PBS containing 1mM CaCl2
and 1mMMgCl2.
50. Fix the cells with 4% w/v paraformaldehyde
(PFA, 400 µL/well of a 24-well plate) for 20min
at RT.
51. Wash three times with PBS.
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52. Dilute the ORO stock solution in ultrapure water (6:4
ratio), incubate 20min at RT and filter through a 0.22µm
nitrocellulose membrane.
53. Add 300 µL/well (of a 24-well plate) of ORO working
solution to the fixed cells and incubate for 2 h at RT with
gentle shaking and protected from light.
54. Exhaustively rinse the monolayer with ultrapure water until
it looks uncolored.
55. Mount the cover slips in an appropriate mounting medium
(e.g., Mowiol, 5 µL/12mm diameter cover slip) for bright
field and fluorescence microscopy analysis, or proceed with
step 53 to perform an indirect immunofluorescence (IFI)
staining.
3.7. Immunofluorescence (IF) of ORO-stained samples.
56. After ORO-staining, incubate the cover slips with 0.05% w/v
saponin in PBS containing 0.2% w/v bovine albumin (BSA),
for 20min.
TIP This step includes permeabilization (due to saponin)
and blocking (due to albumin). The former allows the
antibodies to cross the hASCs membranes, and the later
avoids unspecific binding.
57. Wash three times with PBS, incubating each time for 5min
with gentle shaking.
58. Incubate the monolayer with the appropriate dilution
of primary antibodies in PBS overnight (ON) at 4◦C.
The primary antibodies we used were detailed on the
REAGENTS section.
59. Wash with PBS as in step 54, and then incubate with
the appropriate dilution of fluorescently labeled secondary
antibodies in PBS at RT for 1.5 h. The secondary antibodies
used in our assay were detailed on the REAGENTS section.
TIP If the primary antibody is conjugated to a
fluorophore (as anti-actin-FITC in our assay), this step is
unnecessary.
60. Wash with PBS as in step 51. Mount with Mowiol (including
10 µg/µL Hoechst stain or similar to stain the nucleus).
61. Observe and take images by fluorescence microscopy
(Figure 4A) or laser scanning confocal microscopy. The
combination of filters used in our example was as follows:
Hoeschst, excitation band-pass filter (BPF) 330/385, dichroic
mirror (DM) 445/585, emission BPF 450/485; FITC or
Alexa Fluor-488, excitation band-pass filter (BPF) 460/490,
dichroic mirror (DM) 505/520, emission BPF 520/545; Red
Oil O, excitation band-pass filter (BPF) 520/550, dichroic
mirror (DM) 560/580, emission BPF 590/650.
Images Quantification
TIP The following steps describe the procedure to automatically
quantify ORO-stained cell images using the freely available
software package Octave (Eaton et al., 2015). Basically, we
quantified the number of red-colored pixels in fluorescence or
bright field images and the number of cells from DAPI or
Hoechst-stained nuclei.
62. Copy and paste all images to analyze in a new folder.
63. Use Octave’s image processing functions described by Eaton
et al. (2015) to process images (following steps listed in 62
b-g), or copy and paste our Octave program “OilRed.m”
(freely available upon request) into the same folder and open
Octave package.
64. Open OilRed.m and run the file. The programwill determine
the number of red pixels in all images and will generate a
file containing all image names with their respective pixels
quantification.
While being executed, the program OilRed.m automatically
performs the following steps:
(a) In Octave, it opens the first image (in either.jpg or.tiff
format).
(b) Adjusts colors using the function “imadjust” to intensify red.
(c) Defines colors’ upper and lower limits.
(d) Quantifies pixels falling in these intervals (defined in c) for
the current image.
(e) Saves pixels’ quantification and image files’ names.
(f) The program automatically repeats steps from (a) to (f) with
every image until all of them have been processed.
(g) Generates a file “Table 1.txt”, containing all image files’
names with their respective pixels quantification.
65. To quantify the number of cells within each image, copy and
paste all images to analyze in a new folder.
66. Use Octave’s image processing functions described by Eaton
et al. (2015) to process images (following steps listed in 65
b–h), or copy and paste our Octave program “CellCount.m”
(freely available upon request) into the same folder and open
Octave package.
67. Open and run CellCount.m file, the program will count cells
within the images and will generate a file containing all image
files’ names with their respective cell number quantification.
68. While being executed, the program CellCount.m performs the
following automatic steps:
(a) In Octave, it opens the first image (in either.jpg or.tiff
format).
(b) Adjusts colors using function “imadjust” to intensify the
color of interest.
(c) Converts image to gray scale (250 tones) using the function
“rgb2gray.”
(d) Converts image to black and white (2 tones) using the
function “im2bw.”
(e) Fills small holes in the black and white image using the
function “imfill.”
(f) Quantifies cells using the function “bwlabel.”
(g) Repeats from (a) to (f) with the next image until all of them
have been processed.
(h) Generates a file “Table 2.txt”, containing all image files’
names with their respective cell quantification, which may be
used to normalize the values obtained in step 64(g), statistically
analyzed and graphed as in Figure 4B.
Western Blot Analysis of Adipogenic
Differentiated hASCs
69. Cultivate the hASCs to 80% confluency in two 10 cm
diameter culture plates. Cultivate one of them with 5% v/v
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FIGURE 4 | Lipid droplets and cellular proteins double staining. (A) by Untreated (UT) and differentiated (D) hASCs were Oil Red O (ORO) and immunostained, and
analyzed by fluorescence microscopy. Green signal corresponds to the indicated proteins detected by immunofluorescence (Actin-FITC) or indirect
immunofluorescence (EEA-1, GM 130, ADRP); blue signal corresponds to Hoechst-stained nuclei; red signal corresponds to ORO-stained LDs. (B) Automated
quantification of ORO fluorescence intensity relative units (R.U.) in UT and D hASCs. Bars represent mean values (+/– standard deviation) from 14 ORO-stained
images prepared as in A and normalized to the number of nuclei/image. The asterisk indicates significant differences between samples (Student’s test; p-value <
0.01). Data were similar in two other experiments.
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FBS (untreated), and induce the other one to adipogenic
differentiation following the same protocol explained above
(steps 43–47). Cultivate under standard conditions (37◦C
and 5% CO2) until day 10.
70. Wash the monolayer gently one time with cold PBS buffer,
and add 300 µL of lysis buffer (60mM Tris-HCl, pH 6.8, 2%
w/v SDS, 0.10mM PMSF). Keep the cell culture plate on ice
during this and the next step.
ATTENTION SDS concentration in lysis buffer is critical
to obtain a high quality protein extract in cells containing
numerous and big size LDs, thus a high lipids/protein rate.
71. Detach the cells by using a cell scraper, homogenize by
pipetting up and down, and transfer each lysate to a 1.5mL
microcentrifuge tube.
72. Heat the lysates for 10min at 100◦C, and then place them
on ice.
73. Centrifuge at 13,000 × g for 10min at 4◦C. Take each
supernatant and transfer them to new 1.5mL conical
microcentrifuge tubes.
REST These samples may be stored at −20◦C for weeks
(or at −80◦C for months, depending on the stability of the
proteins of interest to analyze by WB, it may be stored for
years).
74. Measure the total protein concentration by using a suitable
method, as the Bicinchoninic acid assay (BCA assay). We
employ the PierceTM BCA Protein Assay Kit (Thermo Fisher
Scientific).
ATTENTION Do not use the Bradford method for
protein quantification of these lysates, because it is not
compatible with the SDS concentration needed in the lysis
buffer.
75. Prepare 12% SDS-PAGE Tris-Glycine gel, and assemble the
electrophoresis chamber.
76. Prepare the samples by mixing the volume corresponding
to 10 µg of each lysate with the appropriate volume of 5 X
protein sample buffer (see RECIPE).
77. Heat the samples at 90–100◦C for 5min., load them on
the gel and perform electrophoresis. We use initially 130V,
and when the samples reach the resolving gel, we increase
to 190V. With this settings, the electrophoresis takes 1 h
50min.
78. Electro-transfer the proteins to a 0.22µm PVDF (or
nitrocellulose) membrane. Alternatively stain the gel with
Coomassie G250 during 40min., and then use discolor
solution (5% v/v Acetic acid, 30% v/v ethanol) for 1 h until
the background is pale and the protein bands are more
visible.
TIP In our system, PVDF membranes give better results
than nitrocellulose, allowing us to load smaller amounts of
proteins to detect by Western blot (i.e., we load 10 µg for
PVDF and 40 µg for nitrocellulose membrane to get similar
chemiluminescent signal).
79. If electro-transference is performed, use Towbin buffer
(25mMTris-HCl, pH 8.30, 192mMGlycine, 0.10%w/v SDS,
20% v/v methanol) and transfer ON at 10V.
80. The next morning, take the membrane carefully out of the
system and let it dry.
REST Drying the membrane makes the proteins to bind
stronger, and it is also an excellent storage method. The dried
membrane may be stored at RT for weeks before blotting.
81. Incubate the membrane (only for PVDF membranes) in
highly pure methanol for a few seconds to activate it. Briefly
rinse it with water and stain with Ponceau S to evaluate
the transfer quality. Remove excess of Ponceau S staining
solution with water, take image and rinse off the Ponceau S
stain with three PBS washes before starting the Western blot
incubations.
82. Block the membrane by submerging it in 5% w/v non-fat dry
milk in PBS at RT for 30min.
83. Incubate with the primary antibody (anti-actin antibody, BD
Biosciences, dilution 1:3,000) in PBS for 1 h.
84. Wash the membrane three times with PBST (0.01% v/v
Tween-20 in PBS) for 5min.
85. Incubate with an HRP-conjugated secondary antibody (anti-
mouse IgG, Santa Cruz, dilution 1:2,500) in 5% w/v
BSA/0.01% v/v PBST for 1 h.
86. Wash the membrane three times with PBST for 5min, and a
final wash with PBS.
87. Apply the chemiluminescent substrate and enhancer
mixture (Super Signal R© West Pico Chemiluminescent
Substrate, Thermo Fisher Scientific) to the membrane and
incubate 5min.
88. Capture the chemiluminescent signal using a CCD camera-
based equipment (ImageQuantTM LAS 4000—GEHealthcare
Life Sciences) or similar, Figure 5.
ATTENTION A flow chart resuming all steps described
in this protocol can be checked in Figure 6.
ANTICIPATED RESULTS
hASCs are currently considered of high interest, because of
their multipotency and bioactive molecules secretion capacities
(Caplan and Correa, 2011). Figure 1 shows the isolation method
of hASCs from human WAT described here, which yields ∼1 ×
104 cells/g of tissue. Most articles cited the work of Zuk et al.
(2001) as primary source, however, the procedure is not described
in detail there. Our protocol will undoubtedly help filling this gap.
hASCs can be characterized by the expression of specific cell
surface markers. We analyzed hASCs from 5 female individuals
aged 25–65 years old. Figure 2 shows representative outputs of
the flow-cytometry analysis performed for each cell population
derived from a single patient. The results were either similar
to those of Figure 2A or Figure 2B, differing mainly in the
expression of CD105 marker. All were composed by more than
98% CD90+ (mean 98.38 ± 0.44%) and CD73+ (mean 98.74 ±
0.32%) cells, and <2% of cells containing markers of other cell
types (negative cocktail, CD34, CD11b, CD19, CD45, and HLA-
DR, average 1.48 ± 0.09%). For CD105, we obtained either one
of two types of populations from each tissue sample: those with
an average of 98.17 ± 0.49% of cells that express this marker
(Figure 2A) and those with only 1.75± 0.35% of cells expressing
it (Figure 2B). Bourin et al. (2013) suggested that it could be
important distinguishing between the properties of CD105– and
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FIGURE 5 | SDS-PAGE and Western blot analysis of differentiated and control
hASCs. Proteins from whole cell lysates of untreated (UT) or differentiated (D)
hASCs were solved in 12% acrylamide gels and stained with Coomasie blue
(left image). The proteins were transferred to PVDF membranes from an
unstained 12% acrylamide gel and stained with Ponceau S (central image).
Immune anti-β-actin detection in hASCs whole cell lysates. 10 µg of whole cell
lysate were loaded/lane. A representative image from three experiments is
shown.
CD105+ hASCs populations. Indeed, murine ASCs (mASCs)
CD105– were more prone to differentiate into adipocytes and
osteocytes compared to CD105+mASCs (Anderson et al., 2013).
Whether this is the case or not in hASCs populations may be an
interesting issue to analyze.
During adipogenic differentiation of hASCs, LDs increase
in number and size. The adipogenic potential of hASCs tends
to decline with consecutive passages under standard culture
conditions (Li et al., 2017). To induce this process in vitro, we
used low passage (up to 6) hASCs with an optimized drug cocktail
(Gojanovich et al., 2016), based on a comparison of previously
used formulations (Gimble and Guilak, 2003; Lee et al., 2004;
Rodriguez et al., 2004; Dicker et al., 2005; Bunnell et al., 2008;
Zhu et al., 2008; da Silva Meirelles and Covas, 2011; Kim et al.,
2016). These include DMEM (high or low glucose), 10% v/v
FBS, and variable concentrations of Insulin, Dexamethasone,
Indomethacin, or Rosiglitazone, with or without 0.5mM IBMX.
We used the lowest concentration of each drug in a defined
combination showing induction of LDs formation in a time
lapse similar to previously reported (LDs becomes visible 5 days
after induction). Also, the alternation of induction/maintenance
medium (Figure 3) is distinctive to most previous methods,
excepting the published by Qian et al. (2010), which uses
induction cycles on hBMSCs. To prevent the cell detachment,
hASCs where fixed and ORO-stained before reaching the mature
adipocyte stage, which is characterized by a single LD and
a peripheral nucleus. Although ORO-staining requires care to
avoid dye precipitation, once this obstacle is overcome, this cost-
effective stain is as useful as the newest and expensive lipid-dyes,
with the additional advantage that it can be observed by both
bright-field and fluorescence microscopy. Here, we show that
ORO-staining does not interfere with the IF technique, and at
the same time the later does not disturb the LD’s integrity nor
produce cells delipidization. Immediately after ORO-staining,
the IF technique was applied on the same hASCs monolayers.
Figure 4A (first pannel) shows actin disruption upon adipogenic
differentiation (Yang et al., 2014). Additionally, to test our
protocol for LDs (ORO) and cellular proteins (IF) double-
staining, we selected antibodies against proteins from different
subcellular locations (Figure 4A). Although purified LDs have
been reported to recruit the Early Endosome Antigen 1 (EEA1)
(Zehmer et al., 2009), we did not observe changes in EEA1
distribution after adipogenic differentiation (Figure 4A, second
panel). Additionally, Figure 4A (third panel, inset) shows LDs
immersed in the Golgi area (GM130 marker) in differentiated
hASCs. Indeed, during LDs biogenesis in adipocytes, small
nascent LDs are transported from the ER to the Golgi, where
more TAGs are loaded and additional proteins are attached
(Hesse et al., 2013). Later, LDs fusion and degradation are
regulated by LD-coating proteins as Adipocyte differentiation-
related protein (ADRP), among others (Hesse et al., 2013). This
explains co-localization (yellow colored) signal by superposition
of LDs (red) and ADRP (green) signals (Figure 4A, fourth panel,
merge). Images also suggested the presence of nuclear LDs, which
have been recently described (Layerenza et al., 2013). Figure 4B
represents the quantification of ORO fluorescence in untreated
and adipogenic differentiated hASCs.
Finally, we addressed a problem that although not mentioned
in the literature, is well-known among researchers working with
adipose differentiated hASCs. This is that lysates from those cells,
prepared with typical RIPA lysis buffer (50mM Tris-HCl, pH
7.5, 150mM NaCl, 1% v/v NP40, 0.5% w/v Na Deoxicholate,
0.1% w/v SDS) or variants (i.e., with the addition of 0.1%
v/v Triton X-100, or SDS increased to 1% w/v), are not well-
resolved in acrilamide-bisacrilamide Tris-glycine or tris-tricine
gels, resulting in the accumulation of proteins (including actin)
in a single un-resolved band. Protein precipitation with 5%
w/v TCA was partially useful, but a lot of protein was lost in
the process. A much simpler solution was to increase the SDS
concentration in the lysis buffer up to 2% w/v and boil the
sample for 10min before clarification. This procedure was the
only one, allowing the proteins from adipogenic differentiated
hASCs lysates to be efficiently resolved by SDS-PAGE. This can
be observed in a CBB-stained gel (Figure 5, left panel), Pounceau
S-stained PVDF membrane (Figure 5, central panel) and WB
detection with actin-specific antibody (Figure 5, right panel).
In conclusion, our report deals with different important
issues raised when working with hASCs, including details
regarding isolation, characterization, adipogenic differentiation,
ORO-IF combined double staining, and WB analysis (Figure 6).
Given the growing interest in hASCs for research or clinical
purposes, this report will positively impact on a broad public of
researchers.
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FIGURE 6 | Flow chart including all steps described in this protocol. For each activity detailed in the protocol, the corresponding step numbers were indicated on the
side, with an estimation of the earliest day after the plastic surgery in which the activity may be performed.
NOTES
Troubleshooting
No Adherent Cells Are Found 24h After the Procedure
Possible cause 1: Inadequate enzyme concentration. Solution:
Optimize enzymes concentrations. Especially collagenase lots
may vary in activity, and too much activity may kill the cells.
However, too low activity would not digest enough the tissue to
for an adequate stem/stromal cells release.
Possible cause 2: Inadequate enzyme incubation time.
Solution: Optimize enzymes incubation time. The incubation
time may also depend on the enzyme lots and should be adjusted
if necessary. Long time incubation may kill the cells and too
short may not be enough for an adequate stem/stromal cell
release.
Possible cause 3: The cellular pellet (SVF) has been lost.
Solution: This pellet is labile; thus, extreme care should be taken
when aspirating the media from above to avoid aspirating it.
Possible cause 4: The processing time took long time,
which may kill the cells. Solution: Reduce the processing time.
This will arrive with practice, or alternatively increase the
ratio operator/tissue quantities. An experienced operator could
efficiently process in average 100 g of adipose tissue, and this
would take ∼5 processing hours. If processing 200 g of adipose
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tissue, it should only be prolonged for 1 h, as only the mechanical
processing steps will be significantly increased.
Possible cause 5: The sample was not properly prepared in
the operating room. Solution: No antiseptic should be added
(in some liposuction procedures the sample is mixed with an
antiseptic solution). It is also common the addition of formol to
fix the samples for anatomopathology analysis; be sure this is not
done. The sample must be conserved without additives at room
temperature or 4◦C, and never be frozen for this procedure. The
sample should be processed within no more than 3 days, this is
especially critical in lipoaspirate samples, in which the cells are
more exposed and unprotected as in the solid tissue niche.
Possible cause 6: Red blood cells have not been washed away,
which may kill the hASCs. Solution: Make sure to eliminate
most red blood cells by washing exhaustively the next day after
the isolation procedure. These blood cells, may rapidly consume
media nutrients, which may not be available for hASCs.
The Culture Gets Contaminated
If this occurs on the first few days after the procedure,
contamination may have become with the sample. Review with
the nurse the way the samples are collected.
If contamination occurs later, make sure to use correct
aseptic technique and test media, serum and other
reagents to find the contamination source. Use antibiotics
appropriately.
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